大规模功能网络之间高频连接的差异与严重抑郁症和耐治疗抑郁症相关
Ty Lees1,2, Sarah E Woronko1, Mohan Li1
1Center for Anxiety, Depression, and Stress Research, McLean Hospital, Belmont, Massachusetts.
Biological psychiatry global open science
|October 17, 2025
概括
大型抑郁症 (MDD) 和耐治疗抑郁症 (TRD) 显示出不同的神经连接模式. 在默认模式网络 (DMN) 内,以及在贝塔频段的DMN,前端对象网络 (FPN) 和突出网络 (SN) 之间,TRD显示出更强的连接性.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 脑部成像 脑部成像
背景情况:
- 大型抑郁症 (MDD) 和耐治疗抑郁症 (TRD) 与神经连接的改变有关.
- 三重网络模型,包括默认模式网络 (DMN),前沿对称网络 (FPN) 和突出网络 (SN),是理解这些变化的核心.
- 在MDD与TRD之间,这些连接性变化的确切性质和特异性仍然不清楚.
研究的目的:
- 为了比较DMN,FPN和SN之间的高频静止状态功能连接 (rsFC).
- 研究健康对照组 (HC),MDD患者和TRD患者之间的rsFC差异.
- 阐明抑郁症治疗阻力背后的神经机制.
主要方法:
- 休息状态电脑电图 (EEG) 数据从34名MDD,24名TRD和34名HC参与者收集.
- 使用精确的低分辨率电磁断层扫描来估计theta和β rsFC.
- 分析了DMN,FPN和SN之间的连接.
主要成果:
- 与对照人群相比,患有抑郁症 (MDD和TRD组合) 的个体表现出DMN内β1连接的增强.
- 与MDD参与者相比,TRD参与者在DMN,DMN到FPN和FPN到SN的β3连接性显著增加.
- 这些连接性差异甚至在控制当前抑郁症状严重程度后也持续存在.
结论:
- 在DMN,FPN和SN之间和之间,高频 rsFC差异,特别是在β频段,可能是抑郁症治疗抵抗的基础.
- 需要进一步的研究来探索异质性因素的影响,如药物治疗,发病年龄和发病史.
- 了解抑郁期的时间动态对于全面了解神经连接变化至关重要.
相关概念视频
Depressive Disorders: MDD and Dysthymia
627
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
627
Depressive Disorders: Etiology
437
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
437
Depression: Overview
777
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
777
Antidepressant Drugs: MAOIs and Other Agents
806
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
806


